Vonoprazan for Helicobacter Pylori Eradication in Adolescents
Status:
Recruiting
Trial end date:
2024-07-01
Target enrollment:
Participant gender:
Summary
The trial tends to evaluate the efficacy of vonoprazan-based triple therapy in eradicating H.
Pylori infection in adolescent patients in Egypt, in comparison to standard treatment
regimens to determine if it offers superior eradication rates (VONTAPE trial).